You are here

Ipatasertib

Roche Abandons AKT Prostate Cancer Asset

BioSpace

Thu, 02/2/23 - 10:52 am

clinical trials

castration-resistant prostate cancer

prostate cancer

AstraZeneca beats Roche twice in a day

EP Vantage

Wed, 10/26/22 - 10:20 am

ESMO: Roche’s Akt inhibitor scores slight win over J&J’s Zytiga

Fierce Biotech

Sun, 09/20/20 - 08:02 pm

prostate cancer

Roche phase 3 hits goal in subgroup of prostate cancer patients

Fierce Biotech

Fri, 06/19/20 - 11:29 am

clinical trials

prostate cancer

The ipatasertib curate’s egg

EP Vantage

Fri, 06/19/20 - 10:45 am

akt protein inhibitor

prostate cancer

Big pharma heads towards important readouts

EP Vantage

Wed, 05/20/20 - 10:22 am

Gilead Sciences

Avalglucosidase alfa

clinical trials

Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients

BioCentury

Mon, 04/1/19 - 09:32 pm

clinical trials

metastatic triple-negative breast cancer

Genentech granted FDA orphan status for gastric cancer treatment

Yahoo/Fly on the Wall

Fri, 05/2/14 - 09:53 am

cancer of the gastro-esophageal junction